Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?

Carsten Schwarz (Berlin, Germany), Carsten Schwarz, Horst Von Bernuth, Claudia Rolinck-Werninghaus, Jobst Fridolin Roehmel, Susanne Lau, Markus Becker, Maria Deja, Doris Staab

Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Carsten Schwarz (Berlin, Germany), Carsten Schwarz, Horst Von Bernuth, Claudia Rolinck-Werninghaus, Jobst Fridolin Roehmel, Susanne Lau, Markus Becker, Maria Deja, Doris Staab. Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?. Eur Respir J 2016; 48: Suppl. 60, 2559

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Are epidemiological statistics on extrapulmonary tuberculosis correct?
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016


Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


International validation of FACED score in 672 patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016


Evaluation of fatigue state with virus-related novel biomarkers in obstructive lung diseases
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016

Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Clinical features of chronic obstructive pulmonary disease in never smokers
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Role of tuberculosis in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015


Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016

Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Characteristics of essential hypertension in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016


Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Patients’ adherence to chronic treatment of pulmonary diseases
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Bronchiectasis caused by pulmonary tuberculosis: The epidemiology, clinical presentations and the differences from non-tuberculosis-caused bronchiectasis
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013

Chronic obstructive pulmonary disease and comorbidities
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Current maintenance treatment of chronic obstructive pulmonary disease in China
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014


Mortality after COPD-exacerbations: Learning from epidemiology
Source: International Congress 2014 – Clinical presentations
Year: 2014

Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016